The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia

• Status: Recruiting
• Trial end date: 2022-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This will be a randomised control trial designed to test the effectiveness of lactoferrin in the management of treatment-induced anemia in patients with hematological malignancies.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cyprus University of Technology
• Collaborator: Hematological Clinic - Nicosia General Hospital
• Treatments: Epoetin Alfa; Lactoferrin

Criteria

Inclusion Criteria:

• Patients on active treatment (chemotherapy i.e. cyclophosphamide, doxorubicin, rituximab, cisplatin carboplatin, etoposide)

• Ability to independently complete the questionnaires

Exclusion Criteria:

• Allergy to Milk

• Lactose intolerance

• Celiac disease

• Patient of whom chemotherapy has been interrupted for more than 2 weeks (due to adverse effects)